Table A13.
Income | Virological failure (n) | Person-years (1000’s) | Crude rate (95% CI) (per 1000 person years) |
---|---|---|---|
Low/middle | 128 | 3.884 | 32.954 (27.712, 39.188) |
High | 302 | 8.265 | 36.54 (32.642, 40.902) |
Virological failure = 5000 copies/mL; LLV ≤ 5000 copies/mL.
The analysis included all patients who had achieved undetectable viral load (≤ 50 copies/mL) within 1 year of starting combination antiretroviral therapy (cART) and prior to subsequent viral failure, and excluded periods off treatment or on mono/duo for > 7 days.